Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

SAFE-PCI for Women

This study has been terminated.
(Study stopped for Statistical Futility. Low rate of bleeding events made it unlikely there would be statistical power to show a difference in the 2 arms.)
American College of Cardiology Foundation
Abbott Vascular
Lilly USA
Terumo Medical Corporation
The Medicines Company
Acist Medical Systems
FDA - Office of Women's Health
Information provided by (Responsible Party):
Duke University Identifier:
First received: June 20, 2011
Last updated: January 16, 2015
Last verified: January 2015